An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity

被引:30
|
作者
Cervera, AM [1 ]
Apostolova, N [1 ]
Luna-Crespo, F [1 ]
Sanjuan-Pla, A [1 ]
Garcia-Bou, R [1 ]
McCreath, KJ [1 ]
机构
[1] Univ Valencia, Ctr Nacl Invest Cardiovasc, Unidad Mixta Invest, Valencia 46010, Spain
关键词
PHD3; prolyl hydroxylase; hypoxia-inducible factor-1; alternative splicing;
D O I
10.1016/j.canlet.2005.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cellular response to limiting oxygen levels is managed, in part, by the transcription factor hypoxia-inducible factor 1 (HIF-1), and the prolyl hydroxylase (PHD) family of oxygen-requiring enzymes. In the process of analyzing the expression of PHD3, we observed the presence of two alternatively processed PHD3 transcripts, designated PHD3 Delta 1 and PHD3 Delta 4. The expression of both PHD3 and PHD3 Delta 1 was observed in all tissues and cell lines tested, although the expression of the novel PHD3 Delta 4 appeared to be restricted to primary cancer tissues. The function of PHD3 Delta 4 was assessed in transfection experiments showing a preserved prolyl hydroxylase activity. We would submit that PHD3 variants generated by alternative splicing may be intrinsically involved in the complex system of oxygen sensing (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [21] Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer
    Agnieszka A Rawluszko
    Katarzyna E Bujnicka
    Karolina Horbacka
    Piotr Krokowicz
    Paweł P Jagodziński
    BMC Cancer, 13
  • [22] Human PRP19 interacts with prolyl-hydroxylase PHD3 and inhibits cell death in hypoxia
    Sato, Masuhiro
    Sakota, Miki
    Nakayama, Koh
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (17) : 2871 - 2882
  • [23] Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions
    Swain, Lija
    Wottawa, Marieke
    Hillemann, Annette
    Beneke, Angelika
    Odagiri, Haruki
    Terada, Kazutoyo
    Endo, Motoyoshi
    Oike, Yuichi
    Farhat, Katja
    Katschinski, Doerthe M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (03) : 365 - 375
  • [24] Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27
    Hoegel, Heidi
    Miikkulainen, Petra
    Bino, Lucia
    Jaakkola, Panu M.
    MOLECULAR CANCER, 2015, 14
  • [25] Zebrafish phd3 Negatively Regulates Antiviral Responses via Suppression of Irf7 Transactivity Independent of Its Prolyl Hydroxylase Activity
    Yu, Guangqing
    Li, Xiong
    Zhou, Ziwen
    Tang, Jinhua
    Wang, Jing
    Liu, Xing
    Fan, Sijia
    Ouyang, Gang
    Xiao, Wuhan
    JOURNAL OF IMMUNOLOGY, 2020, 205 (04): : 1135 - 1146
  • [26] Combined Deficiency of Prolyl Hydroxylase (PHD) 1 and PHD3 Increases Mesenchymal Stem Cell Number and Regulates the Hematopoietic Stem Cell Niche
    Stegen, Steve
    Khurana, Satish
    van Gastel, Nick
    Torrekens, Sophie
    Moermans, Karen
    Carmeliet, Peter
    Verfaillie, Catherine
    Carmeliet, Geert
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [27] HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
    Petra Miikkulainen
    Heidi Högel
    Krista Rantanen
    Tomi Suomi
    Petri Kouvonen
    Laura L. Elo
    Panu M. Jaakkola
    Cancer & Metabolism, 5
  • [28] Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27
    Heidi Högel
    Petra Miikkulainen
    Lucia Bino
    Panu M. Jaakkola
    Molecular Cancer, 14
  • [29] HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
    Miikkulainen, Petra
    Hogel, Heidi
    Rantanen, Krista
    Suomi, Tomi
    Kouvonen, Petri
    Elo, Laura L.
    Jaakkola, Panu M.
    CANCER & METABOLISM, 2017, 5
  • [30] Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia
    Chaturvedi, Anuhar
    Cruz, Michelle Maria Araujo
    Goparaju, Ramya
    Gabdoulline, Razif
    Schottmann, Renate
    Goerlich, Kerstin
    Kloos, Arnold
    Thol, Felicitas
    Geffers, Robert
    Mougiakakos, Dimitrios
    Carmeliet, Peter
    Ganser, Arnold
    Heuser, Michael
    BLOOD, 2018, 132